As hypoxia promotes radioresistance and immunosuppression,80, 83 a sustained reduction in tumour hypoxia appears to be an attractive strategy to lower immunosuppression and improve the efficacy of combined PD‐1/PD‐L1 blockade therapy and radiotherapy. Here, CD274 is linked to neoplasm.